Shares of Altria Group Inc. (NYSE: MO) retreated in premarket trading Thursday following a second-quarter earnings report that revealed a slight miss on adjusted profit and a notable shift in product mix. The stock was last seen at $72.62, down 3.1% from Wednesday's close of $74.92, ahead of the main NYSE trading session.
The tobacco giant reported adjusted earnings per share of $1.48 for the quarter, falling two cents short of the consensus estimate of $1.50. Revenue, net of excise taxes, came in at $5.356 billion, marginally above the $5.35 billion analyst forecast. Reported EPS was $1.37, a 2.8% decline from $1.41 in the same period last year. Adjusted EPS growth, however, was positive at 2.8%, supported by a lower share count.
Product Mix Shift: Discount Brands Surge
The most significant development in the quarter was the dramatic change in cigarette shipment composition. Marlboro, Altria's flagship premium brand, experienced a 7.4% volume decline, falling by 1.11 billion sticks. In contrast, discount brand shipments surged by 67.3%, adding 598 million sticks. This growth in discount labels offset approximately 54% of the premium volume loss. The share of discount brands in domestic shipments climbed to 9.6%, up from 5.5% in the prior year period.
Total domestic cigarette shipments fell 3.2% to 15.554 billion sticks. Marlboro's retail share slipped 1.5 percentage points to 39.5%, while discount brands gained 1.9 points to capture a 3.9% share. The overall cigarette category retail share for Altria increased by 0.3 point to 45.5%.
Higher pricing and duty refunds helped sustain the financial performance of the smokeable products segment. Adjusted operating companies income, a key profit metric, rose 2.4% to $3.018 billion, with margins expanding by 0.3 percentage point to 64.8%. Segment revenue, net of excise taxes, increased 2.0% to $4.660 billion.
Oral Tobacco Faces Headwinds
The oral tobacco products segment, which includes the on! nicotine pouch brand, reported a 5.2% decline in revenue to $690 million and an 8.0% drop in adjusted segment profit to $460 million. Margins contracted by 2.0 percentage points to 66.7%. Shipments of on! decreased by 4.2%, and its share of the nicotine pouch segment fell by 1.7 points to 14.4%. This occurred even as nicotine pouches expanded their overall share of the oral market to 59.9%, a gain of 8.1 percentage points.
Competition in the pouch category is intensifying. Philip Morris International Inc. (NYSE: PM) reported a 2% increase in ZYN shipments last quarter and recently launched a $1.2 billion manufacturing campus in Colorado. This puts pressure on Altria's ongoing national rollout of on! PLUS, which is now available in 120,000 stores. The company plans to expand distribution of the 12-milligram variant in the third quarter and introduce additional flavors in the fourth.
Outlook and Capital Allocation
Altria tightened its 2026 adjusted earnings per share guidance to a range of $5.61 to $5.72, raising the lower end by $0.05. The company maintained its expectation for increased cigarette import-export gains in the second half of the year. Capital expenditure guidance was raised to $375 million-$450 million from the prior $300 million-$375 million range, with the increase earmarked for integrating smokeless-tobacco production.
Dividends for the first half totaled $3.6 billion, and share repurchases amounted to $335 million, with an additional $665 million still authorized for buybacks. The current quarterly dividend of $1.06 per share, annualized at $4.24, represents approximately 75% of the adjusted EPS midpoint. The premarket decline pushed the indicated dividend yield to about 5.84%.
The outlook assumes NJOY ACE remains off the market throughout 2026. Key risks include faster-than-expected declines in cigarette sales, loss of oral product market share, FDA regulatory actions, illicit vape competition, or litigation that could negatively impact margins and cash distributions.
While Thursday's selloff raises questions about the quality of earnings growth, the cash generation of the cigarette business remains robust. Discount brands have provided a temporary buffer against premium volume erosion, but the on! brand now faces a critical test to capitalize on its market position.
